January 20, 2026

A deep dive into how NeoMag is revolutionizing biomedical research with non-invasive mechanical stimulation.
When traditional research methods fall short in replicating the complexity of biological tissues, innovation becomes essential. Enter NeoMag, the first patented magneto-mechanical platform developed by 60Nd—a spin-off from Universidad Carlos III de Madrid—that provides non-invasive, precise, and dynamic mechanical stimuli to cells and tissues in vitro.
Cellular processes in our body are heavily influenced by mechanical forces. However, most in vitro models fail to incorporate these critical mechanical stimuli, resulting in limited predictive power for real-world biological responses. NeoMag bridges this gap by:
NeoMag’s versatility makes it an invaluable tool across diverse research areas:
NeoMag is uniquely positioned due to its:
NeoMag is already used by leading research institutions globally, including UCSF, Imperial College London, and Johns Hopkins University. A case study in brain trauma demonstrated significant changes (>50%) in cell stiffness, actin remodeling, and altered calcium signaling under mechanical stress, validating NeoMag as a critical tool for mechanobiological research.
The biomedical industry is increasingly recognizing the importance of mechanobiology in therapeutic development. NeoMag is perfectly timed to support the urgent need for physiologically relevant models, addressing a vast market with intersecting interests in regenerative medicine, drug discovery, and laboratory equipment—collectively worth over $300 billion and growing at a CAGR of 7.6%.



